Less glucose variability with insulin detemir compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring

被引：0
|
作者：
Jones, David R.
Clauson, Per
Ong, Stephanie
Mathieu, Chantal
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [21] Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes
    F. Smeeton
    F. Shojaee Moradie
    R. H. Jones
    L. Westergaard
    H. Haahr
    A. M. Umpleby
    D. L. Russell-Jones
    Diabetologia, 2009, 52 : 2317 - 2323
  • [22] Comparison of Glucose Variability Assessed by a Continuous Glucose Monitoring System in Patients with Type 2 Diabetes Switched from NPH Insulin to Insulin Glargine: The COBIN2 Study
    Kvapil, Milan
    Rusavy, Zdenek
    Krivska, Bohumila
    Janickovazdars, Denisa
    Krcma, Michal
    DIABETES, 2011, 60 : A284 - A284
  • [23] Stable isotope studies show differences in effect of insulin detemir and NPH insulin on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in subjects with type1 diabetes
    Hordern, VM
    Wright, JE
    Umpleby, M
    Jacobsen, L
    Draeger, E
    Russell-Jones, DL
    DIABETES, 2002, 51 : A292 - A292
  • [24] Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus
    Breton, Marc D.
    Patek, Stephen D.
    Lv, Dayu
    Schertz, Elaine
    Robic, Jessica
    Pinnata, Jennifer
    Kollar, Laura
    Barnett, Charlotte
    Wakeman, Christian
    Oliveri, Mary
    Fabris, Chiara
    Chernavvsky, Daniel
    Kovatchev, Boris P.
    Anderson, Stacey M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (08) : 531 - 540
  • [25] Variability in Basal Insulin Needs in Young Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring with Predictive Low Glucose Insulin Suspension
    De Tezanos-Pinto, A.
    Pichott, M.
    Barra, A.
    Avila, A.
    Cassorla, F.
    Codner, E.
    Gaete, X.
    Mericq, V
    Roman, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 21 - 22
  • [26] Lower pasting blood glucose (FBG) and less symptomatic hypoglycemia with QD insulin glargine (Lantus®) compared to BID NPH in subjects with type 1 diabetes
    Hershon, K
    Blevins, T
    Donley, D
    Littlejohn, C
    DIABETES, 2001, 50 : A116 - A117
  • [27] Insulin detemir achieves lower, less variable fasting glucose and a reduced risk of nocturnal hypoglycaemia and weight gain compared to NPH insulin in basal bolus therapy of Japanese patients with type 1 diabetes
    Kobayashi, M.
    Iwamoto, Y.
    Kawamori, R.
    Tajima, N.
    Nishida, T.
    Kaku, K.
    DIABETOLOGIA, 2006, 49 : 608 - 609
  • [28] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    DIABETES, 2004, 53 (06) : 1614 - 1620
  • [29] Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes
    Derosa, G.
    Franzetti, I.
    Querci, F.
    Romano, D.
    D'Angelo, A.
    Maffioli, P.
    DIABETES OBESITY & METABOLISM, 2015, 17 (06): : 554 - 559
  • [30] PS1 - 1. Insulin detemir increases cerebral glucose metabolism compared to NPH insulin in human type 1 diabetes: possible explanation for differences in weight gain?
    Larissa W. van Golen
    Marc C. Huisman
    Richard G. IJzerman
    Nikie J. Hoetjes
    Lothar A. Schwarte
    Patrick Schober
    Roel P. Hoogma
    Madeleine L. Drent
    Adriaan A. Lammertsma
    Michaela Diamant
    Nederlands Tijdschrift voor Diabetologie, 2011, 9 (3) : 91 - 91
12345